The largest community of pharma leaders

Be part of our community by subscribing to our newsletters! Follow the steps below.

1. Subscribe to our Announcement Newsletter. You will receive our news about what do you need to know about our work and the resources available for you. 

2. Choose your favorite writer. We constantly look for the top minds on the pharmaceutical marketing industry. You can subscribe to their article on their pages and receive every article on your inbox. 

3. Choose the Newsletter that better fits you needs. We recommend the Editor’s pick to receive everything you need to know in one weekly email. 

You can start here by subscribing to our main Newsletter

NEWSLETTER ANNOUCEMENTS




TPMG FEATURED WRITER NEWSLETTER




Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Natalie Yeadon´s Newsletter




Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Tommaso Salanitri´s Newsletter




“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

EDITOR´S PICK




PHARMACEUTICAL TECHNOLOGY: Is quantum computing pharma’s next big disruptor?

Quantum computing is the next frontier in the field of IT. One industry that is set to benefit significantly...

BIO: Trump’s Revenge on Pharma

The Trump administration unveiled a new drug price control policy, drawing opposition from pharma manufacturers and pharmacy benefit managers. In...

Global Genes Honors Leaders, Advocates, and Innovators in ...

Global Genes, a leading rare disease patient advocacy organization, announces eight award recipients ⁠of diverse backgrounds and experiences through...

Pfizer to start pilot delivery program for its COVID-19...

(Reuters) - Pfizer Inc PFE.N has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as...

U.S. hospitals to restrict Lilly COVID-19 antibody treatment due...

(Reuters) - U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli...

As pharmaceutical execs sell shares worth millions, questions arise

NEW YORK -- Pfizer, Moderna, Novavax: executives at several American laboratories developing COVID-19 vaccines have recently pocketed millions of...

LOOK WHO IS ON THE MOVE!




Soleo Health Names Elizabeth Feldman Vice President Business Development,...

FRISCO, Texas--(BUSINESS WIRE)--Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today...

Legend Biotech Announces Leadership Transition

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and...

Marinus Pharmaceuticals Appoints Christy Shafer as Chief Commercial Officer

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat...

Silverback Therapeutics Expands Executive Team With Appointment of Healthcare...

SEATTLE--(BUSINESS WIRE)--Silverback Therapeutics Inc., a clinical-stage biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop systemically...

Korro Bio Appoints Ram Aiyar, Ph.D., MBA, as Chief...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Korro Bio, Inc., a biotechnology company developing single-base RNA editing therapies, today announced the appointment of Ram...

Transcat Appoints Mark A. Doheny as Chief Financial Officer

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and...

INDUSTRY NEWS




Global Genes Honors Leaders, Advocates, and Innovators in ...

Global Genes, a leading rare disease patient advocacy organization, announces eight award recipients ⁠of diverse backgrounds and experiences through...

Solace Therapeutics Announces that Premier Urology Medical Group Enrolls...

POUGHKEEPSIE, N.Y.--(BUSINESS WIRE)--Premier Urology Medical Group has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical...

Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell...

Intensity Therapeutics Reports Favorable Data of INT230-6 from the...

WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary intratumoral immunotherapy products to kill tumors and increase...

Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today...

Five Prime Announces Bemarituzumab Plus Chemotherapy Demonstrates Significant Progression-Free...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (NASDAQ: FPRX) ), a clinical-stage biotechnology company focused on developing immune...

REGULATORY AFFAIRS




FDA to make emergency use authorization data public for...

(Reuters) - The U.S. Food and Drug Administration said on Tuesday it would make public reviews of all data...

U.S. FDA declines to approve Alkermes’ schizophrenia treatment

(Reuters) - The U.S. Food and Drug Administration did not approve Alkermes’ treatment for schizophrenia and bipolar disorder, the...

CytRx Highlights Orphazyme’s Submission of European Marketing Authorisation for...

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development...

Immune-Onc Therapeutics Announces Orphan Drug Designation of IO-202 (Anti-LILRB4)...

PALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage cancer immunotherapy company today announced that the U.S. Food and...

Forma Therapeutics Announces FT-4202 Receives Orphan Drug Designation in...

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers,...

EUSA Pharma and BeiGene Announce Acceptance of a Biologics...

HEMEL HEMPSTEAD, England & BEIJING, China, & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EUSA Pharma (UK) Limited and BeiGene, Ltd. (NASDAQ: BGNE; HKEX:...

MEDICAL DEVICES




Solace Therapeutics Announces that Associate Urologists of North Carolina...

RALEIGH, N.C.--(BUSINESS WIRE)--Associate Urologists of North Carolina, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR...

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that...

New Alcon Innovations in Intraocular Lenses, Digital Health Solutions...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, will highlight a...

Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development...

BOSTON & LONDON--(BUSINESS WIRE)--Synthace Ltd and Ipsen, a global biopharmaceutical company focused on innovation and specialty care, have partnered...

World’s Leading Home Improvement Retailer Battling COVID-19 Impact with...

MIDDLETOWN, Conn.--(BUSINESS WIRE)--Reality Interactive, a leading retail technology design firm and digital agency in Middletown, Connecticut, announced the launch...

PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency...

HOSPITAL NEWS




Centers for Medicare & Medicaid Services (CMS) Issues Permanent...

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat...

NWN to Present on Advanced Cybersecurity Defense at the...

WALTHAM, Mass.--(BUSINESS WIRE)--A cybersecurity expert from NWN, the leading integrated cloud communications with infrastructure service provider, will lead the...

Tenax Therapeutics Announces Presentation of 24-Hour HELP Study Results...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products for...

Boston Children’s Hospital and Deerfield Join Forces to Accelerate...

BOSTON and NEW YORK--(BUSINESS WIRE)--Boston Children’s Hospital, which has the largest National Institutes of Health-funded pediatric research enterprise in...

New Study Forecasts How COVID-19 Concerns May Affect Elective...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--The Alexander Group, Inc., a revenue growth consultancy, announces insights from its most recent Provider Learnings and...

Swisslog Healthcare Partners with Summa Health to Pilot a...

BROOMFIELD, Colo.--(BUSINESS WIRE)--Swisslog Healthcare, a leading global supplier of integrated solutions for medication management in healthcare environments, announces the...